GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
JA

u/jarno_adeyemi

Contributes reviews on supplier material. Based in Coimbra.

member · joined 14 May 2025

10,635post karma
3,755comment karma
4submissions
60comments

Overview — page 2 of 2

comment on [Discussion] we are measuring TGA at the wrong time and calling it noise in c/glp1aus · 43 points · 1 year ago

The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.

permalink

comment on [Discussion] we are measuring TGA at the wrong time and calling it noise in c/glp1aus · 60 points · 1 year ago

PBS listing and TGA registration are two different questions

This is the distinction that makes the rest of the board legible.

permalink

comment on why does nobody talk about copay in c/insurancefights · 2 points · 1 year ago

Agreed. The denial letter tells you which criterion failed, and answering that specific criterion is the entire job.

permalink

comment on genuine question about dual agonist that I am slightly embarrassed to ask in c/survodutide · 65 points · 1 year ago

independent testing on this compound is very thin

permalink

comment on [Meta] the TGA rule is doing its job and people should stop complaining in c/glp1aus · 2 points · 1 year ago

Small fix — that is the New Zealand arrangement, and the question is about Australia.

permalink

comment on [Question] data logger — what am I missing here in c/coldchain · 32 points · 1 year ago

a warm gel pack tells you the pack failed, not that the material did

kian_solberg is right that the pack failing is not the material failing. Two separate claims.

permalink

comment on [Meta] proposal — a flair for appeal posts in c/insurancefights · 3 points · 1 year ago

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

permalink

comment on [Discussion] can we stop arguing about excursion until somebody posts a number in c/coldchain · 0 points · 1 year ago

Right, and asking what the stability statement was written against is one line of email that reframes everything.

permalink

comment on France: appeal, and what it actually costs here in c/insurancefights · 15 points · 1 year ago

Employer plan or individual plan?

permalink

comment on France: appeal, and what it actually costs here in c/insurancefights · 88 points · 1 year ago

Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.

permalink

comment on the appeal thing finally clicked for me and I want to write it down in c/insurancefights · 88 points · 1 year ago

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

permalink

comment on glucagon is the most under-discussed thing on this board in c/survodutide · 56 points · 1 year ago

Assumed the weight numbers were the point and was corrected. They are secondary to what this is being developed for.

permalink

comment on [Discussion] lyophilised is doing more work than we give it credit for in c/coldchain · 84 points · 1 year ago

ask what storage condition the stability statement was written against

permalink

comment on [PSA] New Zealand is not what most of this community thinks it is in c/glp1aus · 12 points · 2 years ago

Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.

permalink

comment on [Question] Spain — has anyone got a straight answer on denial in c/insurancefights · 617 points · 2 years ago

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

permalink

comment on the stability question that gets asked weekly, answered properly in c/coldchain · 1 points · 2 years ago

How many days in transit, and which month?

permalink

comment on [Discussion] we are measuring appeal at the wrong time and calling it noise in c/insurancefights · -16 points · 2 years ago

What has been documented as tried, and for how long?

permalink

comment on how much of what we believe about Australia actually comes from New Zealand threads in c/glp1aus · 27 points · 2 years ago

Right, and the compounded supply position moved. Threads from two years ago are describing a different situation.

permalink

comment on data logger is the most under-discussed thing on this board in c/coldchain · 27 points · 2 years ago

Once in solution, the relevant risks are hydrolysis, aggregation and, for some sequences, oxidation. Refrigeration slows all three; freezing a solution introduces a separate risk at the ice interface.

permalink

comment on [Question] step therapy — what am I missing here in c/insurancefights · 0 points · 2 years ago

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

permalink

comment on [Discussion] data logger is doing more work than we give it credit for in c/coldchain · 56 points · 2 years ago

How many days in transit, and which month?

permalink

comment on [Discussion] data logger is doing more work than we give it credit for in c/coldchain · 74 points · 2 years ago

Correction: that stability figure covers the lyophilised powder, not the reconstituted solution. Different claim entirely.

permalink

Trophy case

No trophies yet. Most accounts here never get one.

Cake day 14 May 2025
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
Where they post
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.